Shares of NovaBay Pharmaceuticals, Inc. (:NBY) are on our watchlist today as the stock has moved -4.61% from the open, touching $0.45 on a recent trade. While the stock has a nice low price tag to it, does it have any value?

Investors may be combing through all the latest company earnings reports. They may be trying to figure out which companies look like they are going to be strong over the next few quarters. Earnings reports have the ability to cause dramatic stock price swings. Many investors will stay away from making any big trades around earnings announcements. When the dust settles, it may be much easier to determine whether a stock is worth buying or if it should be sold. Keeping a close eye on historical earnings results can provide some good insight. Companies that consistently produce solid earnings may be worth looking into further, especially if the investor is on the fence about getting into the name.

Investors are constantly trying to set themselves up for success when dealing with the stock market. This may mean tracking the market from a variety of alternate angles. Keeping tabs on the overall economic climate can help provide valuable insight. Taking a look at the bigger picture can help investors filter down and sort out issues at the sector and individual company level. Making sense of the seemingly endless amount of data can be quite a challenge for the investor. Once investors become familiar with the data, they can start to devise a plan to help use the information to their advantage. Even though thousands of investors will have access to the same set of data, learning how to trade the data can be extremely important. 

Based on recent analysis, NovaBay Pharmaceuticals, Inc. (:NBY) shares have been seen trading -76.19% off of the 50-day peak and -1.07% away from the 50-day bottom. In terms of the stock price in relation to its moving averages, company shares are -27.41% away from the 20-day moving average and -56.53% off of the 50-day average. If we take a longer approach, shares have been trading -61.45% away from the 200-day moving average.

Occasionally investors may be looking to shift their stock strategy. Maybe one plan worked for a period of time, but now economic conditions have shifted and a change is required. Whatever the case, the primary goal is typically to maximize profits.

Finding a winning investing strategy may not happen immediately. Navigating the sometimes murky economic waters can be a struggle. Staying afloat may depend on many factors, but doing homework and studying all the available information is essential.

Over the last year, NovaBay Pharmaceuticals, Inc. (:NBY)’s stock has performed
-65.75%. For the last six months, the stock has performed -67.50%. From the start of the calendar year, shares have been -42.38%. Zooming in closer, company stock has been -79.20% for the quarter, -48.83% over the past month, and -17.56% over the past week.

Investors are always striving to make wiser decisions when it comes to handling the markets. There are so many options available, and that can make things more complex. Beginning with a solid approach can help ease the investor’s initial foray into the stock market. Accumulating market knowledge may take a lot of time and effort. Many investors may find out the hard way that there is no easy way to beat the markets. Many investors are teased with investment tips from friends or colleagues. It can be very tempting to take advice from someone who has a track record of beating the market. However, the old saying remains the same; past results may not indicate future results. Investors may find that doing their own research can provide a huge boost to portfolio performance.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.